Harte Hanks Financials
This page shows Harte Hanks (HHS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A shrinking revenue base is leaving thin operating profit unable to fund reinvestment, pushing the business back into cash burn.
Between FY2024 and FY2025, current liquidity looked steady with a current ratio near 1.5x even as cash fell from$9.8M to$5.6M . The missing link is cash conversion: a smaller revenue base left operating margin at just0.2% , and operations consumed-$1.7M instead of replenishing cash.
In FY2025, EBITDA remained positive at
Accounts receivable fell from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Harte Hanks's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Harte Hanks scores 14.52, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Harte Hanks passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). No profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Harte Hanks generates $2.14 in operating cash flow (-$1.7M OCF vs -$811K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Harte Hanks generated $159.6M in revenue in fiscal year 2025. This represents a decrease of 13.9% from the prior year.
Harte Hanks's EBITDA was $4.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 25.0% from the prior year.
Harte Hanks reported -$811K in net income in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Harte Hanks earned $-0.11 per diluted share (EPS) in fiscal year 2025. This represents an increase of 97.3% from the prior year.
Cash & Balance Sheet
Harte Hanks generated -$4.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 33.3% from the prior year.
Harte Hanks held $5.6M in cash against $0 in long-term debt as of fiscal year 2025.
Harte Hanks had 7M shares outstanding in fiscal year 2025. This represents an increase of 0.8% from the prior year.
Margins & Returns
Harte Hanks's operating margin was 0.2% in fiscal year 2025, reflecting core business profitability. This is down 0.9 percentage points from the prior year.
Harte Hanks's net profit margin was -0.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.1 percentage points from the prior year.
Harte Hanks's ROE was -4.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.2 percentage points from the prior year.
Capital Allocation
Harte Hanks invested $2.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 26.4% from the prior year.
HHS Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.3M-6.5% | $39.9M+0.9% | $39.5M+2.3% | $38.6M-7.0% | $41.6M-11.8% | $47.1M-1.1% | $47.6M+5.8% | $45.0M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $5.6M-0.7% | $5.7M+10.3% | $5.1M-7.0% | $5.5M-5.2% | $5.8M+2.0% | $5.7M+8.9% | $5.3M-10.1% | $5.9M |
| Operating Income | -$768K-556.4% | -$117K-123.0% | $509K+1397.1% | $34K+185.0% | -$40K+97.4% | -$1.6M-181.8% | $1.9M+38.2% | $1.4M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | -$370K+85.3% | -$2.5M-196.3% | $2.6M+3439.7% | -$78K+63.7% | -$215K-137.7% | $570K-34.3% | $868K+109.6% | -$9.0M |
| Net Income | -$628K-128.5% | $2.2M+196.3% | -$2.3M-582.4% | -$335K+14.5% | -$392K-101.4% | $27.1M+18950.7% | $142K+100.5% | -$27.8M |
| EPS (Diluted) | $-0.08 | N/A | $-0.31-520.0% | $-0.050.0% | $-0.05 | N/A | $0.02+100.5% | $-3.84 |
HHS Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $90.4M-1.5% | $91.8M-1.0% | $92.7M-2.4% | $95.0M-5.5% | $100.6M-1.2% | $101.8M-5.9% | $108.1M-1.5% | $109.7M |
| Current Assets | $45.8M-1.2% | $46.3M-4.9% | $48.7M-2.6% | $50.0M-6.9% | $53.7M+0.2% | $53.6M-0.4% | $53.8M-2.2% | $55.0M |
| Cash & Equivalents | $4.5M-18.8% | $5.6M-14.3% | $6.5M+36.9% | $4.8M-45.4% | $8.7M-11.3% | $9.8M+65.0% | $5.9M-45.8% | $11.0M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $26.1M-6.2% | $27.8M-7.8% | $30.2M-12.2% | $34.4M+16.3% | $29.6M-6.5% | $31.6M-4.9% | $33.3M+8.9% | $30.6M |
| Goodwill | $295K0.0% | $295K0.0% | $295K0.0% | $295K0.0% | $295K0.0% | $295K-84.7% | $1.9M0.0% | $1.9M |
| Total Liabilities | $70.3M-1.4% | $71.3M-2.1% | $72.8M+0.1% | $72.8M-8.1% | $79.2M-1.2% | $80.1M-8.0% | $87.1M-2.3% | $89.1M |
| Current Liabilities | $30.7M+1.9% | $30.2M-8.6% | $33.0M+5.7% | $31.2M-13.5% | $36.1M+2.7% | $35.1M-4.9% | $36.9M+1.5% | $36.4M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $20.1M-2.1% | $20.5M+3.2% | $19.9M-10.6% | $22.2M+3.8% | $21.4M-1.2% | $21.7M+3.0% | $21.0M+2.1% | $20.6M |
| Retained Earnings | $813.2M-0.1% | $813.8M+0.3% | $811.6M-0.3% | $813.9M0.0% | $814.2M0.0% | $814.6M-0.3% | $817.1M0.0% | $816.9M |
HHS Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$575K-178.0% | $737K-76.9% | $3.2M+165.9% | -$4.8M-492.9% | -$818K-120.2% | $4.0M+237.2% | -$2.9M-283.3% | $1.6M |
| Capital Expenditures | $347K-75.6% | $1.4M+41.5% | $1.0M+351.1% | $223K+112.4% | $105K-83.3% | $627K-67.2% | $1.9M+180.2% | $682K |
| Free Cash Flow | -$922K-34.4% | -$686K-131.3% | $2.2M+143.2% | -$5.1M-449.6% | -$923K-127.0% | $3.4M+170.3% | -$4.9M-624.7% | $926K |
| Investing Cash Flow | -$347K+75.6% | -$1.4M-41.4% | -$1.0M-347.1% | -$225K-118.4% | -$103K+83.5% | -$626K+67.2% | -$1.9M-180.2% | -$682K |
| Financing Cash Flow | -$50K-22.0% | -$41K+73.5% | -$155K-119.9% | $778K+1244.1% | -$68K+27.7% | -$94K+42.3% | -$163K-1153.8% | -$13K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | $0 | $0 | N/A |
HHS Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -2.1%-1.8pp | -0.3%-1.6pp | 1.3%+1.2pp | 0.1%+0.2pp | -0.1%+3.2pp | -3.3%-7.3pp | 4.0%+0.9pp | 3.0% |
| Net Margin | -1.7%-7.2pp | 5.5%+11.3pp | -5.8%-4.9pp | -0.9%+0.1pp | -0.9%-58.3pp | 57.4%+57.1pp | 0.3%+62.1pp | -61.8% |
| Return on Equity | -3.1%-13.9pp | 10.7%+22.2pp | -11.5%-10.0pp | -1.5%+0.3pp | -1.8%-126.6pp | 124.7%+124.1pp | 0.7%+135.7pp | -135.1% |
| Return on Assets | -0.7%-3.1pp | 2.4%+4.9pp | -2.5%-2.1pp | -0.4%+0.0pp | -0.4%-27.0pp | 26.6%+26.4pp | 0.1%+25.5pp | -25.4% |
| Current Ratio | 1.49-0.0 | 1.54+0.1 | 1.48-0.1 | 1.60+0.1 | 1.49-0.0 | 1.53+0.1 | 1.46-0.1 | 1.51 |
| Debt-to-Equity | 3.50+0.0 | 3.47-0.2 | 3.66+0.4 | 3.27-0.4 | 3.700.0 | 3.69-0.4 | 4.14-0.2 | 4.32 |
| FCF Margin | -2.5%-0.8pp | -1.7%-7.3pp | 5.5%+18.7pp | -13.1%-10.9pp | -2.2%-9.5pp | 7.2%+17.4pp | -10.2%-12.3pp | 2.1% |
Similar Companies
Frequently Asked Questions
What is Harte Hanks's annual revenue?
Harte Hanks (HHS) reported $159.6M in total revenue for fiscal year 2025. This represents a -13.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Harte Hanks's revenue growing?
Harte Hanks (HHS) revenue declined by 13.9% year-over-year, from $185.2M to $159.6M in fiscal year 2025.
Is Harte Hanks profitable?
No, Harte Hanks (HHS) reported a net income of -$811K in fiscal year 2025, with a net profit margin of -0.5%.
What is Harte Hanks's EBITDA?
Harte Hanks (HHS) had EBITDA of $4.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Harte Hanks's operating margin?
Harte Hanks (HHS) had an operating margin of 0.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Harte Hanks's net profit margin?
Harte Hanks (HHS) had a net profit margin of -0.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Harte Hanks's return on equity (ROE)?
Harte Hanks (HHS) has a return on equity of -4.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Harte Hanks's free cash flow?
Harte Hanks (HHS) generated -$4.5M in free cash flow during fiscal year 2025. This represents a 33.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Harte Hanks's operating cash flow?
Harte Hanks (HHS) generated -$1.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Harte Hanks's total assets?
Harte Hanks (HHS) had $91.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Harte Hanks's capital expenditures?
Harte Hanks (HHS) invested $2.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Harte Hanks's current ratio?
Harte Hanks (HHS) had a current ratio of 1.54 as of fiscal year 2025, which is generally considered healthy.
What is Harte Hanks's debt-to-equity ratio?
Harte Hanks (HHS) had a debt-to-equity ratio of 3.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Harte Hanks's return on assets (ROA)?
Harte Hanks (HHS) had a return on assets of -0.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Harte Hanks's cash runway?
Based on fiscal year 2025 data, Harte Hanks (HHS) had $5.6M in cash against an annual operating cash burn of $1.7M. This gives an estimated cash runway of approximately 39 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Harte Hanks's Altman Z-Score?
Harte Hanks (HHS) has an Altman Z-Score of 14.52, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Harte Hanks's Piotroski F-Score?
Harte Hanks (HHS) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Harte Hanks's earnings high quality?
Harte Hanks (HHS) has an earnings quality ratio of 2.14x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Harte Hanks?
Harte Hanks (HHS) scores 31 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.